N Blumberg1, D J Triulzi, J M Heal
1Department of Pathology, University of Rochester Medical Center, NY 14642.
Homologous blood transfusions can suppress immune function, potentially improving transplant survival and Crohn's disease outcomes. However, this immune suppression may also increase risks for cancer recurrence and infections.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: